SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/23/2025 at 07:00, 7 months 8 days ago

Communiqué de presse : Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe
Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple. Recommandation basée sur l'étude de phase 3 GMMG-HD7 montrant amélioration significative de la SSP

Myélome Multiple Approbation Sarclisa CHMP GMMG-HD7
PRESS RELEASE

published on 06/23/2025 at 07:00, 7 months 8 days ago

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
Sarclisa recommended for EU approval by CHMP for transplant-eligible newly diagnosed multiple myeloma based on GMMG-HD7 study. Potential to improve outcomes in frontline setting globally

Multiple Myeloma Sarclisa EU Approval GMMG-HD7 Study CHMP Recommendation
BRIEF

published on 06/20/2025 at 07:05, 7 months 11 days ago

La FDA approuve le Dupixent pour le traitement de la pemphigoïde bulleuse

Approbation De La FDA Dupixent Pemphigoïde Bulleuse Inflammation De Type 2 Maladie Cutanée Rare
BRIEF

published on 06/20/2025 at 07:05, 7 months 11 days ago

FDA Approves Dupixent for Bullous Pemphigoid Treatment

FDA Approval Dupixent Type 2 Inflammation Bullous Pemphigoid Rare Skin Disease
PRESS RELEASE

published on 06/20/2025 at 07:00, 7 months 11 days ago

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Dupixent approved in the US as the only targeted medicine for bullous pemphigoid, meeting the critical treatment needs of patients with uncontrolled disease

FDA Approval Chronic Disease Dupixent Type 2 Inflammation Bullous Pemphigoid
PRESS RELEASE

published on 06/20/2025 at 07:00, 7 months 11 days ago

Communiqué de presse : Dupixent est approuvé aux États-Unis comme le seul médicament ciblé pour traiter les patients atteints de pemphigoïde bulleuse
Dupixent approuvé par la FDA aux États-Unis pour traiter la pemphigoïde bulleuse, offrant une nouvelle approche ciblée contre l'inflammation de type 2. Résultats positifs de l'étude ADEPT

FDA Dupixent Pemphigoïde Bulleuse Inflammation De Type 2 Étude ADEPT
BRIEF

published on 06/17/2025 at 13:45, 7 months 14 days ago

Sanofi Successfully Prices €1.5 Billion Bond Issue

Bond Issue Corporate Financing Sanofi Fixed-rate Notes Euro Medium Term Note
BRIEF

published on 06/17/2025 at 13:45, 7 months 14 days ago

Sanofi fixe avec succès le prix d'une émission obligataire de 1,5 milliard d'euros

Emission D'obligations Sanofi Financement Des Entreprises Obligations À Taux Fixe Billet À Moyen Terme En Euros
PRESS RELEASE

published on 06/17/2025 at 13:40, 7 months 14 days ago

Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
Sanofi place 1,5 milliard d’euros d’emprunts obligataires avec succès pour financer ses besoins généraux. Citigroup et RBC Capital Markets ont agi en tant que coordinateurs

Sanofi Citigroup RBC Capital Markets Emprunts Obligataires Besoins Généraux
PRESS RELEASE

published on 06/17/2025 at 13:40, 7 months 14 days ago

Press release: Sanofi successfully prices €1.5 billion bond issue
Sanofi successfully prices €1.5 billion bond issue with fixed-rate notes across 2 tranches, using proceeds for general corporate purposes, led by Citigroup and RBC Capital Markets, under Euro Medium Term Note Programme

Financial Markets Bond Issue Sanofi Euro Medium Term Note Programme Fixed-rate Notes

Published on 01/31/2026 at 03:15, 1 day 13 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 14 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 15 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 16 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 17 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 1 day ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 4 hours ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 13 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 18 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 20 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 22 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 22 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 22 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 22 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 8 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News